---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-031593"
form_type: "8-K/A"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:35:20.059277+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Unicycive Therapeutics corrects warrant expiration dates via 8-K/A amendment

## Summary
- Filing corrects inadvertent clerical error in Expiration Date on Exhibits 4.2 and 4.3 (Amended Tranche B and C Warrants) from Original 8-K.
- No other changes made to Original Filing; all terms of Exchange Agreement and Amended Certificate of Designation remain unchanged.
- Original March 2024 event exchanged 43,649,000 Series A-2 Preferred shares for Series A-2 Prime Preferred and amended warrants with reduced share counts and revised exercise price of $1,000.
- Corrected exhibits reflect accurate expiration dates; no impact on conversion prices or aggregate exercise amounts.

## SEC filing metadata
- accession: 0001213900-25-031593
- form_type: 8-K/A
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/0001213900-25-031593-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/ea0237290-8ka1_unicyc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-031593
- JSON: https://secwatch.observer/filing/0001213900-25-031593.json
- Plain text: https://secwatch.observer/filing/0001213900-25-031593.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.